EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials

Jananee Padayachee, Moganavelli Singh iD

Nanobiomedicine · 2020

DOI: 10.1177/1849543520983196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanobiomedicine, 2020. Verfasst von Jananee Padayachee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nano-Gene and Drug Delivery Laboratory, Discipline of Biochemistry, School of Life Sciences, College of Agriculture, Engineering and Science, Univers…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, approximately 1 in 4 cancers in women are diagnosed as breast cancer (BC). Despite significant advances in the diagnosis and therapy BCs, many patients develop metastases or relapses. Hence, novel therapeutic strategies are required, that can selectively and efficiently kill malignant cells. Direct targeting of the genetic and epigenetic aberrations that occur in BC development is a promising strategy to overcome the limitations of current therapies, which target the tumour phenotype. The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system, composed of only an easily modifiable single guide RNA (sgRNA) sequence bound to a Cas9 nuclease, has revolutionised genome editing due to its simplicity and efficiency compared to earlier systems. CRISPR/Cas9 and its associated catalytically inactivated dCas9 variants facilitate the knockout of overexpressed genes, correction of mutations in inactivated genes, and reprogramming of the epigenetic landscape to impair BC growth. To achieve efficient genome editing in vivo, a vector is required to deliver the components to target cells. Gold nanomaterials, including gold nanoparticles and nanoclusters, display many advantageous characteristics that have facilitated their widespread use in theranostics, as delivery vehicles, and imaging and photothermal agents. This review highlights the therapeutic applications of CRISPR/Cas9 in treating BCs, and briefly describes gold nanomaterials and their potential in CRISPR/Cas9 delivery.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerCRISPR/Cas9genome editinggold nanoclustersgold nanoparticles

Autor:innen und Institutionen

  • Nano-Gene and Drug Delivery Laboratory, Discipline of Biochemistry, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal (Westville Campus), Durban, South Africa.

ORCID-Profile: Moganavelli Singh

Zitieren

APA

Padayachee, J., & Singh, M. (2020). Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials. Nanobiomedicine. https://doi.org/10.1177/1849543520983196

Vancouver

Padayachee J, Singh M. Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials. Nanobiomedicine. 2020. doi:10.1177/1849543520983196

BibTeX
@article{Padayachee2020,
  author = {Padayachee, Jananee and Singh, Moganavelli},
  title = {Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials},
  journal = {Nanobiomedicine},
  year = {2020},
  doi = {10.1177/1849543520983196}
}
Kostenlos starten →